Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.18 is 22% below its 5-year average of 2.80, around the middle of its 5-year range (1.17–4.20).
As of the fiscal period ended Tuesday, June 30, 2026. 28.38% below its 12-month average of 3.05.
Reported quarterly quick ratio; no daily interpolation.
QUICK RATIO (ACID-TEST)
2.18
QUICK RATIO (ACID-TEST) AVG TTM
3.05
QUICK RATIO (ACID-TEST) AVG 3Y
3.38
QUICK RATIO (ACID-TEST) AVG 5Y
2.80
QUICK RATIO (ACID-TEST) AVG 10Y
3.23
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-28.38%
CURRENT VS 3Y AVG
-35.34%
CURRENT VS 5Y AVG
-21.98%
CURRENT VS 10Y AVG
-32.28%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.21
median of 89 covered companies
CURRENT VS SECTOR MEDIAN
+80.52%
vs the sector median at left
Market Cap
$56.43B
Quick Ratio (Acid-Test)
0.49
TTM Avg
0.49
3Y Avg
0.52
5Y Avg
0.54
Market Cap
$50.08B
Quick Ratio (Acid-Test)
3.77
TTM Avg
3.27
3Y Avg
2.83
5Y Avg
2.71
Market Cap
$49.58B
Quick Ratio (Acid-Test)
0.51
TTM Avg
0.69
3Y Avg
0.70
5Y Avg
0.80
Market Cap
$66.98B
Quick Ratio (Acid-Test)
0.74
TTM Avg
0.86
3Y Avg
0.89
5Y Avg
1.02
Market Cap
$43.08B
Quick Ratio (Acid-Test)
0.71
TTM Avg
0.79
3Y Avg
0.83
5Y Avg
0.90
Market Cap
$42.89B
Quick Ratio (Acid-Test)
0.67
TTM Avg
0.78
3Y Avg
0.74
5Y Avg
0.73
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $56.28B | 2.18 | 3.05 | 3.38 | 2.80 |
| Cardinal Health, Inc. (CAH)vs › | $56.43B | 0.49 | 0.49 | 0.52 | 0.54 |
| Edwards Lifesciences Corporation (EW)vs › | $50.08B | 3.77 | 3.27 | 2.83 | 2.71 |
| Becton, Dickinson and Company (BDX)vs › | $49.58B | 0.51 | 0.69 | 0.70 | 0.80 |
| Cencora, Inc. (COR)vs › | $63.65B | 0.58 | 0.54 | 0.53 | 0.55 |
| Humana Inc. (HUM)vs › | $48.71B | 1.74 | 0.58 | 0.57 | 0.58 |
| Boston Scientific Corporation (BSX)vs › | $66.98B | 0.74 | 0.86 | 0.89 | 1.02 |
| IQVIA Holdings Inc. (IQV)vs › | $43.08B | 0.71 | 0.79 | 0.83 | 0.90 |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.89B | 0.67 | 0.78 | 0.74 | 0.73 |
| Agilent Technologies, Inc. (A)vs › | $41.67B | 1.56 | 1.54 | 1.63 | 1.68 |
Quick Ratio
2.18
Excludes inventory
Current Ratio
2.29
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.18 |
| 2026-03-31 | 2.35 |
| 2025-12-31 | 3.22 |
| 2025-09-30 | 3.73 |
| 2025-06-30 | 3.77 |
| 2025-03-31 | 4.14 |
| 2024-12-31 | 3.62 |
| 2024-09-30 | 4.20 |
| 2024-06-30 | 3.92 |
| 2024-03-31 | 3.91 |
| 2023-12-31 | 3.36 |
| 2023-09-30 | 2.35 |
| 2023-06-30 | 3.16 |
| 2023-03-31 | 3.26 |
| 2022-12-31 | 2.54 |
| 2022-09-30 | 1.80 |
| 2022-06-30 | 1.71 |
| 2022-03-31 | 1.56 |
| 2021-12-31 | 1.60 |
| 2021-09-30 | 1.25 |
| 2021-06-30 | 1.17 |
| 2021-03-31 | 1.33 |
| 2020-12-31 | 1.42 |
| 2020-09-30 | 2.43 |
| 2020-06-30 | 17.30 |
| 2020-03-31 | 9.29 |
| 2019-12-31 | 7.89 |
| 2019-09-30 | 7.40 |
| 2019-06-30 | 6.77 |
| 2019-03-31 | 7.17 |
| 2018-12-31 | 7.02 |
| 2018-09-30 | 6.00 |
| 2018-06-30 | 5.81 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 4.09 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
